JHS Svendgaard narrows net loss to ₹192.24 lakh in FY26

1 min read     Updated on 30 May 2026, 03:59 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

JHS Svendgaard Laboratories Limited narrowed its net loss to ₹192.24 lakh for FY26 from ₹1,974.43 lakh in the previous year, while revenue from operations increased to ₹10,169.47 lakh. The board approved the audited financial results on May 26, 2026, and the statutory auditors issued an unmodified opinion.

powered bylight_fuzz_icon
40831443

*this image is generated using AI for illustrative purposes only.

JHS Svendgaard Laboratories Limited narrowed its net loss to ₹192.24 lakh for the financial year ended March 31, 2026, from a loss of ₹1,974.43 lakh in the previous year. Revenue from operations for the year rose to ₹10,169.47 lakh, compared to ₹9,199.73 lakh in FY25, while total income stood at ₹10,514.34 lakh. The company's board of directors approved the audited standalone and consolidated financial results at a meeting held on May 26, 2026. The statutory auditors, M/s V.K. Khosla & Co., issued an unmodified opinion on the financial results.

Financial Performance

The company reported a basic and diluted earnings per share (EPS) of (₹0.22) for FY26, an improvement from (₹2.37) in the prior year. For the quarter ended March 31, 2026, the net loss was ₹356.56 lakh, with revenue from operations at ₹3,269.57 lakh. The board also took note of the Auditor’s Report issued by the statutory auditors. The paid-up equity share capital of the company stands at ₹8,740.58 lakh, comprising 8,74,05,767 equity shares of ₹10 each, following the conversion of warrants.

Metric FY26 (₹ in lakh) FY25 (₹ in lakh)
Revenue from Operations 10,169.47 9,199.73
Total Income 10,514.34 9,487.44
Net Profit/(Loss) (192.24) (1,974.43)
Basic EPS (₹) (0.22) (2.37)

Operational and Capital Details

The company utilized funds raised through preferential allotment for projects in Jammu and Kashmir, general corporate purposes, and capital expenditure. Capital advances amounting to ₹3,252.75 lakh for facilities in Himachal Pradesh and ₹1,328.30 lakh for projects in Jammu & Kashmir were considered recoverable by the management. The auditors noted material weaknesses in internal financial controls over financial reporting, specifically regarding the reconciliation of trade receivables and payables, and the identification of non-moving inventory. The meeting was conducted pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for JHS Svendgaard Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.63%-9.74%-11.05%-22.62%-39.35%-65.20%

What specific measures will management implement to address the material weaknesses identified in internal financial controls?

How will the capital advances for the Himachal Pradesh and Jammu & Kashmir facilities impact production capacity in the coming fiscal year?

Is the company on track to achieve a net profit in FY27 given the significant reduction in losses year-over-year?

JHS Svendgaard Laboratories
View Company Insights
View All News
like19
dislike

JHS Svendgaard confirms no encumbrance on promoter shares for FY26

1 min read     Updated on 20 May 2026, 05:32 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

JHS Svendgaard Laboratories Limited disclosed that its promoters and promoter group members did not create any direct or indirect encumbrance on shares during FY26. The confirmation, dated April 01, 2026, was submitted under Regulation 31(4) of SEBI Takeover Regulations and covers four individuals including Mr. Nikhil Nanda.

powered bylight_fuzz_icon
40780804

*this image is generated using AI for illustrative purposes only.

JHS Svendgaard Laboratories Limited has informed the stock exchanges that its promoters and members of the promoter group have not created any encumbrance on their shares during the financial year 2025-2026. This disclosure was submitted in accordance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The company confirmed that neither direct nor indirect encumbrances were established on the respective shares held by the promoters during the specified period. The communication, dated April 01, 2026, was addressed to the Audit Committee of the company, BSE Limited, and the National Stock Exchange of India Limited for their information and records.

Promoter Details

The disclosure covers the following individuals and entities identified as promoters and members of the promoter group as on March 31, 2026:

S. No. Name(s) Category
1. Mr. Nikhil Nanda Promoter
2. Mrs. Sushma Nanda Promoter Group
3. Mr. Daljit Singh Grewal Promoter Group
4. Late Sh. Harish Chander Nanda Promoter Group

The statement was submitted on behalf of all promoters and members of the promoter group by Nikhil Nanda, a Promoter of the company.

Historical Stock Returns for JHS Svendgaard Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.63%-9.74%-11.05%-22.62%-39.35%-65.20%

How might the promoters' decision to maintain unencumbered shareholding influence investor confidence and potential institutional interest in JHS Svendgaard Laboratories going forward?

Could the clean encumbrance record strengthen JHS Svendgaard's position if the company seeks to raise capital through debt or equity instruments in the near future?

With Late Sh. Harish Chander Nanda still listed as a promoter group member, how might the eventual transfer or redistribution of his shareholding impact the promoter holding structure and control dynamics?

JHS Svendgaard Laboratories
View Company Insights
View All News
like18
dislike

More News on JHS Svendgaard Laboratories

1 Year Returns:-39.35%